Hilliard Lyons Upgrades Meridian Biosciences (VIVO) to Buy
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.10 +6.49%
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
Hilliard Lyons upgraded Meridian Biosciences (NASDAQ: VIVO) from Neutral to Buy with a price target of $22.00.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $19.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades L&T Financial Holdings (LTFH:IN) to Buy
- UBS Upgrades CaixaBank SA (CABK:SM) (CAIXY) to Buy
- RBC Capital Upgrades Lakefront Biotherapeutics (LKFT) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
Hilliard LyonsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
